FUJIFILM VisualSonics, Inc.
Greg Nesbitt is a seasoned executive with extensive experience in the healthcare and medical imaging industries. Currently serving as Vice President, Global High Frequency at FUJIFILM VisualSonics, Inc. since April 2018, Greg leads global P&L for ultra-high frequency ultrasound and photoacoustic imaging. Prior roles include Vice President of Healthcare Alliances and National Accounts at Philips, where responsibilities included managing relationships with major US healthcare providers and leading sales teams in the Southeastern United States. Greg's experience also includes leadership positions at Wolters Kluwer Health and GE Healthcare, where significant growth was achieved in diagnostics and cardiovascular ultrasound. Greg holds a Bachelor of Arts in Business Administration and Management from North Carolina State University.
This person is not in any teams
This person is not in any offices
FUJIFILM VisualSonics, Inc.
FUJIFILM VisualSonics designs and manufactures ultra high frequency ultrasound imaging systems, for both research and clinical use. FUJIFILM VisualSonics specifically focuses on developing ultrasound technology that has been scaled to much higher frequencies than commonly found in many of the conventional ultrasound systems on the market today. As a result, our ultrasound platform provides images at resolutions that far exceed any other system available on the market; as fine as 30 micrometers, clearly differentiating our company from our competitors. Our preclinical customers are mostly academic researchers, often involved in the fields of cardiovascular and cancer research. Neurobiology and developmental biology are other key areas that are among an ever growing number of applications. Early in 2016, we launched a new ultra high frequency ultrasound system for clinical use. It is extremely gratifying to be at the forefront of this new field. Initial applications for clinical use of our ultra high frequency technology includes neonatology and pediatrics, vascular, small parts, MSK and dermatology. Visit www.vevomd.com for more information. Beyond ultrasound, we have also developed a unique photoacoustic technology to expand on the capabilities of our imaging solutions. Photoacoustics is the combination of optical and acoustic imaging, and provides additional and complementary information to what can be seen with ultrasound alone. Examples of this include assessment of blood oxygenation levels, detection of other tissues such as melanin or lipids, or visualization of optical dyes or contrast agents not detectable with ultrasound. Our purpose statement at FUJIFILM VisualSonics is as follows: ‘Through bold innovation, we empower those dedicated to the advancement of human health’. This purpose motivates us to develop the highest quality ultra high frequency ultrasound and photoacoustic imaging products.